Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women aged 18 or older
- People who have had breast-conserving surgery (removal of the tumour but not the whole breast) or full breast removal (mastectomy)
- People whose cancer has spread to at least one nearby lymph node (called pN1 or higher), regardless of breast cancer type
- People whose surgery removed all cancer with clear edges around it (no cancer cells found at the edges of the removed tissue)
- People for whom doctors have recommended radiation treatment to the whole breast and nearby lymph nodes
- People whose cancer has been confirmed to not have spread to other parts of the body
- People whose individual risk of breast tissue hardening (fibrosis) from radiation has been assessed using a specific centralised test called the NovaGray RILA Breast® test
- People who live close enough to the trial site to attend follow-up appointments
- People who have signed and dated a consent form agreeing to take part
- People enrolled in the French national social security system
Who may not be able to join:
- People whose cancer has spread to distant parts of the body (metastases)
- People who have or have had cancer in both breasts at the same time or previously, unless the other breast had only a very early, non-invasive change (called an in situ lesion)
- People who have had another type of cancer (other than breast cancer) in the past 5 years, unless it was a common skin cancer (basal or squamous cell) or a very early cervical change — and people with a previous cancer must have been cancer-free for at least five years
- People with serious ongoing health conditions affecting the heart, kidneys, liver, lungs, or other body systems that could prevent long-term follow-up
- People who have taken part in another drug trial in the past 30 days (observational studies that only collect data may be acceptable — confirm with trial site)
- People with an untreated underactive thyroid (hypothyroidism)
- People known to be HIV positive
- People known to have a rare genetic condition that makes them unusually sensitive to radiation (confirm with trial site)
- People who are pregnant or breastfeeding
- People who are unable to meet the study requirements for geographic, personal, or health reasons, or who are unable to understand what the study involves
- People who are under legal guardianship, protective custody, or who have had their personal liberty restricted
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: BOURGIER CELINE, Institut du Cancer de Montpellier - Val d'Aurelle
Phone: 0467613102
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Rate of patients without any grade 2 and more toxicities within the planning target volume
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.